Jiaxin Liang

4.0k citations
69 papers · 2.4k indexed · 1 hit paper · h-index 22
Topics
Cancer-related Molecular Pathways (8 papers)Advanced Breast Cancer Therapies (7 papers)Advanced biosensing and bioanalysis techniques (6 papers)

In The Last Decade

Jiaxin Liang

64 papers receiving 2.4k citations

Hit Papers

The cancer metabolic reprogramming and immune response20212026202220242021250500750

Peers

Jiaxin Liang
Comparison fields: 5 of 119
  • Molecular Biology 1.3k
  • Cancer Research 785
  • Oncology 653
  • Immunology 423
  • Pulmonary and Respiratory Medicine 349
Replace Lei Zhou with:
Lei Zhou China
Dongsheng Huang China
Jing Peng China
Peng Sun China
Sung-Gil Chi South Korea
Jihui Hao China
Juan Zhang China
Ke Wei China
Qiuran Xu China
Qiwei Yang China
Jiaxin Liang relative to Lei Zhou China Lei Zhou's profile →
Citations per field
00.5×3.3×
Lei Zhou · 1×
Citations per year

Countries citing papers authored by Jiaxin Liang

Since Specialization
Citations

This map shows the geographic impact of Jiaxin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxin Liang more than expected).

Fields of papers citing papers by Jiaxin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxin Liang. The network helps show where Jiaxin Liang may publish in the future.

Co-authorship network of co-authors of Jiaxin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxin Liang. A scholar is included among the top collaborators of Jiaxin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxin Liang. Jiaxin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 1
4 1
5 1
6 14
7 1
8 2
9 10
10 14
11 15
12 9
13 33
14 23
15 16
16 68
17 6
18 65
19 8
20 8

About Jiaxin Liang

Jiaxin Liang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 69 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Cancer Research (785 citations), Oncology (653 citations) and Immunology (423 citations). Jiaxin Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Longzheng Xia, Qianjin Liao, Linda Oyang, Yujuan Zhou, Shiming Tan, Shan Rao, Jinguan Lin, Min Su, Pin Yi and Yaqian Han. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026